Objective: To determine the incidence and effects of tricuspid regurgitation (TR) after surgery for mitral valve (MV) repair for mitral regurgitation (MR) due to degenerative disease.
See Editorial page 108.
This study was prompted by a presentation by Joanna Chikwe at the 2015 Annual Meeting of The American Association for Thoracic Surgery (AATS) in Seattle, where she reported on a series of 645 patients who had mitral valve (MV) repair for degenerative disease and 419 (65%) of them had concomitant tricuspid annuloplasty (TA) because of moderate tricuspid regurgitation (TR), tricuspid annular diameter !40 mm by echocardiography, or direct inspection of the tricuspid valve (TV) in equivocal cases. 1 Because 83% of the patients who TA had mild, trace, or no TR, the mean diameter of the tricuspid annulus was 38.8 mm, and more than one half of all patients had advanced myxomatous degeneration of the MV (which often involves the TV too), we argued that the rate of TA was excessively high and unnecessary. Robert Dion clearly disagreed with our views and gave the indications when TA should be combined with MV surgery in a recent editorial. 2 A brief review of our data confirmed our views expressed at the AATS meeting. 3 In another editorial in the Journal, Richard Shemin put things in perspective and correctly stated that we need more evidence and less personal opinions on issues as perplexing as functional TR. 4 This study examined the incidence of TR and its consequences in a large cohort of patients who had MV repair for mitral regurgitation (MR) due to degenerative diseases during the last 3 decades. When we first began a program of MV repair for MR in mid-1980s, we overlooked the TVunless the right side of the heart was dilated grossly at surgery or the patient had had evidence of right-side heart failure preoperatively because we believed that the TR would resolve after correction of the left-side lesion. Moreover, in reviewing the echocardiographic reports from studies done in the 1980s and 1990s, we found that the TV also was overlooked frequently by the echocardiographers because their written reports contained no information on the functional status of this valve or simply stated that the right-sided valves were normal without quantification of TR. We observed, however, that a few patients developed transient right-side failure during the first weeks after MV repair and that these patients often had echocardiographic evidence of moderate or severe TR before surgery; as a result, we increased the rate of TAs we performed over time.
PATIENTS AND METHODS
Isolated MV repair for MR due to degenerative diseases of the MV was performed in 1171 patients by one surgeon from 1985 to 2010. The clinical outcomes of MV repair on these patients were published recently in 2 separate reports, but the issue of concomitant TR was not addressed. 5, 6 We used the database from those 2 reports to design this study. Our patients were followed by the referring cardiologists, and both patients and cardiologists were contacted by our research personnel periodically (yearly during the first 2-3 years and approximately every 2-3 years thereafter), and an echocardiogram was requested to assess MV and ventricular function.
The echocardiograms were read by various cardiologists, who sent us a written report. Valve regurgitation was recorded as none, trivial, mild, moderate, and severe (if a report read ''mild to moderate,'' it was counted as moderate and if read ''moderate to severe,'' it was counted as ''severe'') and entered in a dedicated database. Most echocardiographic reports from 1980s and early 1990s had detailed information on the aortic and MVs but scant information on TV, and sometimes read ''normal right-side valves.'' In 119 patients who had no preoperative echocardiographic data on the TV, we used the TR grading obtained in the operating room (transepicardial echocardiography in the first couple of years of the study and transesophageal since 1988). Postoperative studies that reported the TV as ''normal'' but contained no information of the severity TR were excluded from analysis. Since the publication of the guidelines by American Society of Echocardiography in 2003, all reports contained detailed information on all 4 heart valves. 7 The diameter of the tricuspid annulus was only sporadically measured and not entered in the datasets.
Adverse events were reported according to the guidelines set by cardiac surgical societies. 8 The cause of death was determined by hospital chart review, death certificates, or information from the physician who was caring for the patient at that time. Clinical follow-up was complete in 98.1% (defined as patient having a terminal event or being contacted within 2 years from our previous reports on MV repair 5, 6 ). Echocardiography was performed in all patients in the operating room and before discharge from hospital. Echocardiographic data were available in 95.7% of patients alive at the last follow-up. The overall mean follow-up was 9.1 AE 5.3 years, but it was shorter at 6.9 AE 4.9 years for patients who had TA combined with MV repair for the aforementioned reasons. Twelve patients with TR had leaflet prolapse and were included in the group as functional TR. This study was approved by the Review Ethics Board of the University Health Network and patients' consent waived.
Statistical Analysis
Data are presented as means with standard deviation, median with interquartile range (25th and 75th percentile), and frequencies as appropriate. Comparisons of patients' clinical profile and perioperative outcomes (Tables 1 and 2) were performed by either the Fisher exact test, Wilcoxon 2-sample test, or Student t test assuming unequal variance between groups, as appropriate. Visual inspection of the distribution for continuous variables was used to assess normality. Factors associated with preoperative moderate/severe TR and undergoing concomitant TA were modeled with a logistic regression models (see below for model building strategy). Recognizing that patients included in this study were at risk of multiple postoperative outcomes at the same time, a nonparametric competing risk model was developed. In this model, patients could transition to 1 of 5 possible endpoints, whichever occurred first. These endpoints are listed to follow, with the remaining of the patients being alive and free from reoperation or moderate/severe MR or TR: reoperation for isolated MR; reoperation for isolated TR; reoperation for concomitant MR/TR; reoperation for reasons other than MR or TR; or death before reoperation.
Cox proportional hazard was used to identify factors associated with postoperative mortality. For both the binary and time-dependent outcomes, the strategy for model building was similar. For the first time, outcomespecific univariable regression models were used to screen potential risk factors (Table E1) , and risk factors with univariable P values <.20 were then included in a bootstrap resampling algorithm (1000 random resamples). Variables with a high reliability (ie, selection in >50% of the samples) were then included in a multivariable regression models with backward selection of variables to obtain a final model. TR over time was modeled with the use of longitudinal mixed models, with backward selection of variables that were statistically significant at the univariable level to obtain a final model. Mean imputation was used for 
RESULTS

Preoperative and Intraoperative Characteristics and Perioperative Outcomes
A total of 1171 patients were included in this study, of whom 1116 (95.3%) underwent isolated MV repair and 55 (4.7%) underwent combined MV repair and TA. Table 1 shows the clinical profile and operations performed in all patients and stratified by whether the patient underwent concomitant TA. Not all patients who had moderate or severe preoperative TR had concomitant TA, and as shown in Figure 1 , and the probability of undergoing concomitant TA in those patients increased with later year of surgery (hazard ratio [HR], 1.10/year, 95% CI, 1.04-1.16, P <.001), indicating increasing awareness of a potential TR problem over time. In addition to year of operation, other factors associated with undergoing concomitant TA are listed in Table 4 . Those factors included greater preoperative TR grade, lower preoperative ejection fraction, congenital heart septal disease, greater preoperative functional class, and older age at operation. Early postoperative outcome stratified by isolated MV repair versus MV repair with concomitant TA are listed in Table 2 and showed an expectedly worsened postoperative profile in patients with concomitant MV repair and TA. Figure 2 shows long-term competing outcomes separately for all patients (upper panel), for patients without or with moderate/severe preoperative TR or concomitant TA (middle and lower panels respectively). Prevalence at various time points of all competing outcomes over time since initial surgery is listed in Table 5 . There were 6 early and 178 late deaths: 82 valve or cardiac-related, 93 noncardiac or valvular, and 3 unknown causes. The operative mortality was greater in patients who had TA (0.4% vs 3.6%, P ¼.03). There were 43 (3.7%) reoperations for recurrent MR (38 patients) or MR with TR (5 patients) but no reoperation for isolated TR, although severe TR was the principal cause of death in 2 elderly patients deemed ''inoperable.'' A total of 10 patients had reoperation for reasons other than MR or TR. Multivariable factors associated with postoperative mortality are listed in Table 6 and included older age at surgery, early year of operation, lower LV grade, preoperative hypertension, preoperative AF, postoperative (<1 month) AF, and postoperative (<1 month) pacemaker implantation. Removing the 2 postoperative risk factors from the model did not add or remove any preoperative risk factors from the final model. Interestingly, the presence of TR preoperatively was associated with increased odds of mortality in univariable analyses (HR, 1.99, 95% CI, 1.37-2.89, P <.001) but failed to meet the reliability threshold of 50% (reliability: 24.6%) and did not reach statistical significance when added to the multivariable model described previously (HR, 1.19, 95% CI, 0.81-1.76, P ¼.38).
Long-Term Outcomes
Incidence of Factors and Outcomes Associated with Postoperative TR
The development of TR after MV repair in patients without preoperative TR was rare. Moderate preoperative TR resolved in all but 3 patients and in 8 of 10 with severe preoperative TR, but 15 developed TR again during the follow-up. The incidence of moderate/severe TR over time is reported in Figure 3 with point estimates at 1, 5, 10, and 15 years and is provided in Table 7 along with stratification by preoperative TR and TA. Of note, <5% of postoperative TR was in the severe range. Factors associated with isolated postoperative TR by multivariable analysis are shown in Table 8 and included older age at operation, unrepaired preoperative moderate/severe TR, and the development of postoperative MR.
Impact of Performing TA in Patients With
Preoperative Moderate-Severe TR on Long-Term Outcomes Moderate or severe preoperative TR was associated with an increased risk of postoperative mortality, but performance of TA did not reduce the risk (Figure 4 ). Eleven patients who had TA developed recurrent moderate TR during the follow-up (7 had had DeVega annuloplasty, 3 Simplici-T band, and 1 Carpentier ring).
DISCUSSION
This study examined the incidence and effect of TR in a large cohort of patients who had MV repair for degenerative diseases. TR was addressed infrequently during the first half of this experience and only patients with evidence of right-side failure had TA. As we became more aware of TR, we began to correct TR at the time of MV repair with a consequent increase in the number of TA over time, as documented in Figure 1 and Table 4 . We found that moderate or severe TR at the time of MV repair for degenerative diseases of the MV was associated with older age, impaired left ventricular function, AF, more advanced symptoms of congestive heart failure, congenital heart septal defects, and female sex by multivariable analysis (Table 3 ). This study showed that these patients probably should have TA at the time of MV repair but long-term survival is reduced because of the associated risk factors rather than the presence of TR. This is another compelling reason to correct MR before patients develop advanced symptoms of heart failure, left ventricular dysfunction, or AF. As we stated during the discussion of the paper by Chikwe and colleagues 1 at the AATS meeting in 2015, the development of isolated TR after MV repair for degenerative disease was uncommon in our patients, and it was associated with advanced age at operation, unrepaired preoperative moderate/severe TR, and the development of postoperative MR as shown in Table 6 . Forty-five patients developed isolated moderate or severe TR after MV repair, but 11 of them had had TA. In addition, 11 patients developed recurrent severe MR and moderate or severe TR. The estimated risk of developing isolated moderate or severe TR was 13.6% at 15 years after MV repair in all patients. In the study by Chikwe and colleagues, 1 TR occurred in 9% of patients who did not have TA and in 3% of those who did only 5 years after surgery.
Murashita and colleagues 9 reported an incidence of TR similar to ours after MV repair for degenerative diseases in a cohort of 479 patients who were followed for a mean of 7.5 years. They found that AF and the grade of TR before surgery were associated with the development of severe TR late postoperatively. This finding endorses the performance of TA in patients with moderate or severe TR. Yilmaz and colleagues 10 from the Mayo Clinic examined the outcomes of 693 patients who had isolated MV repair for MR due to MV prolapse and 16% had moderate or severe TR before surgery. They excluded patients with coronary artery disease and congenital heart defects. They observed a significant reduction in the overall grade of TR within the first 3 years but a slight increase after 5 years. Female sex, preoperative AF, and diabetes mellitus were independent risk factors for increased TR with time. 10 A more recent evaluation of this issue at that institution confirmed that MV repair as well as MV replacement reduced TR grade postoperatively and the development of new TR was uncommon.
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Although the number of patients who developed severe TR after MV repair was low in our study (less than 5% of recurrent TR was greater than moderate), the effect of severe TR was devastating, with a high rate of mortality at 1 year after diagnosis, which usually was made during an episode of heart failure. Topilsky and colleagues 12 from the Mayo Clinic examined the outcomes of 353 patients (mean age 70 years) with isolated TR and found that an effective regurgitant orifice !40 mm 2 was associated with marked reduction in survival independent of all characteristics, right ventricular size or function, comorbidity, or pulmonary pressure and lower than expected in the general population. Other investigators have found that severe TR after implantation of transvenous pacemaker was associated with poor long-term survival. It is worth mentioning that insertion of permanent transvenous pacemaker after TA does not seem to increase the risk of TR. 14 We have been performing the maze procedure for AF only since 1996 and that is the reason why only 133 of 235 with AF at the time of surgery had combined MV repair with maze. We could not establish a relationship between maze and postoperative TR, but it has been suggested that the maze procedure reduces the risk of postoperative TR if successful in eliminating AF. 15 Dreyfus and colleagues 16 introduced the concept that annular dilatation precedes the development of TR and a tricuspid annulus !70 mm in the arrested heart (the distance from the commissure between septal and anterior leaflets to the base of the posterior leaflet) should be an indication for TA regardless of TR grade. Nemoto and colleagues 17 examined a large number of patients with no or trace TR, mild TR, and moderate or severe TR by echocardiography and computed tomography and found TV annular dilatation and atrial enlargement comprise early events in mild functional TR and atrial enlargement occurs before right ventricular dilation, which occurs late, when TR is severe. They concluded that atrial volume and TV annular dilatation are early and sensitive indicators of TR. 17 The shape of the tricuspid annulus changed from elliptical to circular with severe TR. 17 This study supports the concept that tricuspid annulus dilatation may precede functional TR. The European guidelines on the management of functional TR suggests that a preoperative echocardiographic TV annulus !40 mm is an indication for TA (class IIa, level C). 18 Several surgeons have incorporated this recommendation into their practice, and the rate of TA at the time of MV repair has soared to as high 65%. 1, 2, 19, 20 These investigators argued that the right ventricle remodels after TA in patients with dilated tricuspid annulus. 1, 19 The assessment of right ventricular size and function, however, is difficult and often inaccurate. 21 Moreover, a recently published echocardiographic study Sordelli and colleagues 22 from Milan, Italy, which included 3-dimensional imaging, failed to show a correlation between the diameters of the TV annulus (anteroposterior and septolateral) and the development of TR after MV repair for degenerative diseases, and the authors concluded that ''newly developed significant TR is a rare event after successful repair of degenerative MR.'' Based on our findings, postoperative functional TR is uncommon after MV repair for degenerative diseases, and we have identified factors associated with its development except for the role of the diameter of the TV annulus. Approximately 22% of our patients had advanced myxomatous degeneration with voluminous MV leaflets and large annulus, and these patients frequently also have voluminous tricuspid leaflets. Thus, a single measurement of 40 mm as the cut-off point of dilated TV annulus is probably inappropriate. It may be too large for patients with small TV leaflets such as in patients with MR due to fibroelastic deficiency and too small for patients with MR due to advanced myxomatous degeneration. We believe that further studies are needed to define the implications of TV annular dilatation.
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Finally, TA is associated with recurrent TR in a relatively high proportion of patients as documented in this study, but we and others have shown that the type of TA is an important determinant of recurrent TR, and rigid rings and bands provide more durable repair than suture annuloplasty.
23,24
Limitations of the Study
As with most retrospective studies, this one has several limitations. Patients operated on during the first decade of this experience did not have detailed echocardiographic reports on the TV. Echocardiographic studies were performed in multiple laboratories, and we used the written report to enter postoperative MR and TR grades into our database. Together, these 2 points raise the possibility that we have underestimated the prevalence of TR both preoperatively and in the postoperative period in this study. In addition, although this study provides a unique long-term perspective on outcomes after MV repair, an era effect cannot be excluded through which risk factors once considered important no longer are and newly identified risk factors might have an effect that was not taken in account in the current study. We had no data on heart rhythm before the day of surgery or postoperatively until in the latter parts of the follow-up, preventing us from better defining the role of postoperative AF as well as the maze procedure in the development of TR. Finally, we must acknowledge that the patient population examined represents the practice of one surgeon. Our statistical analyses attempted to risk adjust within the unique context of our patient population, but we make no claims regarding the generalizability of those risk models to the wider patient population either clinically or statistically.
CONCLUSIONS
Patients with MR due to degenerative diseases develop TR because of older age, chronic AF, advanced functional class, impaired left ventricular function, congenital heart septal defects, and female sex. These factors adversely affect long-term survival, and TA does not seem to restore life span to the level of patients without TR. Patients with moderate and severe TR at the time of MV repair probably should have concomitant TA to reduce the probability of developing TR. New TR after MV repair is uncommon during the first 15 years of follow-up, but when it happens it is associated with poor prognosis largely because of the factors associated with it. The findings of this study are compelling reasons to recommend MV repair early on the course of severe MR due to degenerative diseases.
Webcast
You can watch a Webcast of this AATS meeting presentation by going to: http://webcast.aats.org/2016/ Video/Monday/05-16-16_Hall_E_0730_David-800.mp4.
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Authors have nothing to disclose with regard to commercial support. ''In reviewing the echo reports from studies done in the 1980s and the 1990s we found that the TV was frequently overlooked by echocardiographers because their written reports contained no information on functional status of the valve or, simply stated, that the right-side valves were normal without quantification. With time we realized that a few patients developed transient right-side failure during the first couple of weeks after mitral repair and they often had evidence of moderate to severe TR before surgery.'' This is probably one of the most important issues of your presentation, as you are telling us that you had no preoperative data concerning the tricuspid valve, and let's hope that you will not tell us that these data were available at the time of surgery under anesthesia, because then you would agree that grading would then become completely irrelevant, even more so for the tricuspid valve than for the mitral valve. So how can you therefore conclude that there is no TR increase as you have no reference point? You did say you had 138 who had moderate severe TR preoperatively but only 55 received an annuloplasty. Why the others did not and what was their outcome?
But overall, can you seriously say from your data that TR is uncommon after mitral valve repair and do you think that your data supports such statements. Table 1 in your manuscript, which assigns a grading to the 1171 patients subdivided into none, mild, moderate, and severe. But accordingly to American College of Cardiology/American Heart Association and European Society of Cardiology echo guidelines, only none/mild and severe TR can be identified. Moderate TR is not quantifiable. This is why in our paper from 2005 we stressed that annular dilatation was more relevant than TR grading, and, if I understand well, you have mixed up in this assignment, data from transesophageal echocardiography and data before surgery, which I think from a methodology standpoint is not fair.
It is funny enough to stress that you had about 13% of patients who showed moderate and/or severe TR, the same number as the Mayo Clinic did, who also denies that it is an ongoing process, the same figure as we had in our paper in 2005 to which you refer. They also had an increase up to 30% and they said this was not a problem, as you are saying that it is not a problem. It is not a question of data analysis, it is the interpretation of it which seems to be wrong. Dr David. I don't quite understand your question, because these patients were followed prospectively. They had an echo every 2 or 3 years. Yes, in the 1980s and the 1990s the cardiologists didn't look at the tricuspid valve as they do now. So the reports frequently read normal right side valves. So I assumed that if it's normal there was no severe leakage.
Dr Dreyfus. Sorry, for an average European surgeon or French surgeon, it's difficult to understand. If you enter data and you go back to your data 25 years back you are telling me it is prospective? This is a retrospective analysis. You looked at the echo of the patients 25 years ago. Moreover, you relied on echos performed by referring cardiologists and not according to a core laboratory review. It does indeed weaken your analysis even if prospective.
Dr David. The patients were followed prospectively. I looked back 25 years, but our patients were followed prospectively, not retrospectively. The patients who had mitral valve repair, I saw them at 2 or 3 months, did an echo. The cardiologists continued following every year, had more echoes. They were followed prospectively.
Dr Dr D. Adams (New York, NY). Tirone, it's a pity we didn't have a microphone to record our dinner conversation together last night as we could have played it now. We have been discussing your paper for a while. I said last night I was going to tell everyone that I have always respected you as a master surgeon, but now I know you are a master magician as well. It is ''magical'' to suggest your analysis is an answer to our paper presented by Joanna Chikwe last year where we described a contemporary series of more than 600 patients treated exactly the same way in the operating room, with a preoperative echo grade of TR not just from the intraoperative transesophageal echocardiography but on preoperative studies, and describing long-term postoperative data on degree of tricuspid regurgitation, functional class, right atrial size, pulmonary hypertension, and the recovery of right ventricular dysfunction.
So I don't think that your retrospective analysis exactly ''answers'' the paper we presented last year; there are a lot of limitations . you agree? Dr David. I agree entirely. Any retrospective analysis has limitations, although the patients were followed prospectively.
Dr Adams. They were followed, Tirone, but as Gilles stated, many cardiologists ''lost'' in Canada didn't read his paper in 2005 and probably have not read subsequent published papers on functional tricuspid valve disease. So one still wonders, were they really assessing tricuspid valve function postoperatively? We don't really know. The one thing we do know is your patients survived after surgery, right? Survival was not impacted, but you didn't present data on functional class, and we don't know if they will continue to survive. So you don't really know what the impact of moderate or severe TR is on your patients. Agree? Dr David. Agree. I had 8 minutes to present. I went over a minute to present this paper. The functional class bears no relationship to tricuspid regurgitation. And we have an actuarial in the manuscript. We plotted cumulative functional classes 3 and 4 versus tricuspid regurgitation. Only 2 patients developed heart failure.
Dr Adams. Okay. Tirone, because the moderators are going to cut us off, I just have a few more questions I have to raise. One is, I am going to do your mitral valve repair for degenerative disease. In 4 years would you like an echo that says mild or no TR or one that finds moderate TR?
Dr David. No TR. Dr Adams. So we agree that, even though you have not demonstrated a clinical impact of not addressing moderate TR in your patients, you want a more aggressive approach today because you don't want TR after your mitral valve repair. That's why in the conclusion of your manuscript, which you didn't present today, that you now recommend tricuspid repair if you have moderate TR. Dr David. It was one of the items that moderate TR caused more TR afterwards and it affected survival, so we should repair it, moderate and severe, but not mild. In your paper three-fourths of them had no TR or mild TR.
Dr Adams. Okay, Tirone. So let me ask about a patient in our paper. If you see tomorrow a 65-year-old patient with severe MR, mild TR, right ventricular dilatation, moderate pulmonary hypertension, and ejection fraction of 55%, and their tricuspid diameter is 45, are they going to get an operation? Dr David. Yes, they are. Dr Adams. Are they going to get a tricuspid repair with mitral repair? Dr David. Absolutely. Dr Adams. But they only have mild TR. Dr David. But the annulus is dilated. Dr Adams. Exactly, they have other risk factors. Dr David. They should have tricuspid annuloplasty. Dr Adams. And this is the take-home message, because you and I have talked a lot about this since last year. Tirone, I just want to summarize that there are a lot of patients who benefit from concomitant tricuspid valve repair, including patients that don't have moderate or severe TR, and that is based on risk factors for progression of disease. So I think that we agree on. We also agree that tricuspid annular dilatation in a Barlow's patient, for example, may be less important than in a patient with a smaller valve and fibroelastic deficiency. Perhaps we have to be more proscriptive in Postoperative MR grade (<1 mo after procedure)y 3.6% Postoperative TR grade (<1 mo after procedure)y 3.6%
NYHA, New York Heart Association; LV, left ventricular; TR, tricuspid regurgitation; MR, mitral regurgitation. *Not included in models for preoperative TR grade. yIncluded only in models of long-term outcomes.
